PSC
ONC

Patient Square Capital’s BeOne Medicines Ltd ONC Stock Holding History

Patient Square Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.9M Buy
80,542
+11,230
+16% +$3.64M 4.24% 4
2025
Q4 		$21.1M Buy
+69,312
New +$22.7M 4.51% 5

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Patient Square Capital's ONC Position: Q1 2026 in Review

Patient Square Capital increased its BeOne Medicines Ltd (ONC) stake by 16% in Q1 2026, buying an estimated $3.64M and bringing the position to 80,542 shares worth $23.9M. The position accounts for 4.24% of the portfolio, ranked #4.

Patient Square Capital first reported a position in ONC in Q4 2025 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Patient Square Capital held 80,542 shares of BeOne Medicines Ltd worth $23.9M as of Q1 2026.
  • Patient Square Capital bought 11,230 BeOne Medicines Ltd shares in Q1 2026, an estimated $3.64M.
  • BeOne Medicines Ltd made up 4.24% of Patient Square Capital's portfolio in Q1 2026, its #4 holding.
  • Patient Square Capital first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Patient Square Capital's 13F filing for Q1 2026, filed 15 May 2026.